Virtus Fund Advisers’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-5,087
Closed -$560K 548
2016
Q2
$560K Sell
5,087
-5,081
-50% -$506K 0.01% 324
2016
Q1
$964K Sell
10,168
-2,230
-18% -$188K 0.01% 283
2015
Q4
$1.12M Sell
12,398
-129
-1% -$10.9K 0.01% 277
2015
Q3
$1.16M Sell
12,527
-28,241
-69% -$2.49M 0.01% 271
2015
Q2
$2.68M Sell
40,768
-568
-1% -$37.7K 0.02% 285
2015
Q1
$2.96M Sell
41,336
-3,803
-8% -$206K 0.02% 277
2014
Q4
$1.72M Buy
45,139
+218
+0.5% +$6.88K 0.01% 344
2014
Q3
$1.11M Sell
44,921
-3,094
-6% -$78.4K 0.01% 390
2014
Q2
$1.21M Buy
+48,015
New +$1.12M 0.01% 422

Other funds holding ABMD

Virtus Fund Advisers's ABMD Position: Q3 2016 in Review

Virtus Fund Advisers sold out of Abiomed Inc (ABMD) in Q3 2016, closing a stake of 5,087 shares — an estimated $560K sold.

Virtus Fund Advisers first reported a position in ABMD in Q2 2014 and held it in 9 quarters. The position peaked at $2.96M in Q1 2015. 305 funds tracked by Wall St. Rank hold ABMD as of Q3 2016.

  • Virtus Fund Advisers reported no remaining Abiomed Inc position as of Q3 2016 after selling out during the quarter.
  • Virtus Fund Advisers sold 5,087 Abiomed Inc shares in Q3 2016, an estimated $560K.
  • Virtus Fund Advisers first reported a position in Abiomed Inc in Q2 2014 and held it in 9 quarters.
  • Virtus Fund Advisers's Abiomed Inc position peaked at $2.96M in Q1 2015.
  • 305 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2016.

Based on Virtus Fund Advisers's 13F filing for Q3 2016, filed 10 Nov 2016.